Package 31722-365-31

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 31722-365-31
Digits Only 3172236531
Product NDC 31722-365
Product ID 31722-365_323f6641-3d42-70d0-e063-6294a90aaf61
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (31722-365-31)

Marketing

Marketing Status
Marketed Since 2024-10-15
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Azacitidine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "323f6641-3d42-70d0-e063-6294a90aaf61", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0331722365314"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["f02c9bef-e47f-4b70-95f6-9341d87346ed"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (31722-365-31)", "package_ndc": "31722-365-31", "marketing_start_date": "20241015"}], "brand_name": "Azacitidine", "product_id": "31722-365_323f6641-3d42-70d0-e063-6294a90aaf61", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "31722-365", "generic_name": "Azacitidine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA215765", "marketing_category": "ANDA", "marketing_start_date": "20241015", "listing_expiration_date": "20261231"}